|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Possis Medical, Inc. (POSS) to Release Second Quarter Results on February 20
2/13/2008 9:25:49 AM
MINNEAPOLIS--(BUSINESS WIRE)--Possis Medical, Inc. (NASDAQ: POSS), a developer, manufacturer and distributor of pioneering medical devices used in endovascular procedures, announced today that it will report complete results for its second quarter ended January 31, 2008, at 7:00 a.m. (CT) on Feb. 20, 2008. Based on preliminary results, Possis indicated that it currently expects net sales of approximately $20.6 million for the second quarter, a 30 percent increase from fiscal 2007 second-quarter sales of $15.8 million. In its outlook issued on Nov. 21, 2007, the Company had estimated second-quarter net sales of $18.7 million to $19.2 million. Possis anticipates second quarter net income to fall within its previously issued guidance range of $0.03 to $0.05 per diluted share, compared to a net loss of $0.04 per diluted share in the second quarter of fiscal 2007.
|
|
|
|
|
|
|
|
|
|
|